The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1

Journal of Virology

Volumn 85, Issue 9, 2011, Pages 4184-4197

  Allen, Sariah J ^a   Hamrah, Pedram ^b   Gate, David ^c   Mott, Kevin R ^a   Mantopoulos, Dimosthenis ^b   Zheng, Lixin ^b   Town, Terrence ^c   Jones, Clinton ^d   von Andrian, Ulrich H ^b   Freeman, Gordon J ^b   Sharpe, Arlene H ^e   BenMohamed, Lbachir ^f   Ahmed, Rafi ^g   Wechsler, Steven L ^f   Ghiasi, Homayon ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN B; INTERLEUKIN 2; INTERLEUKIN 21; LAT PROTEIN; MESSENGER RNA; MUCIN; PROGRAMMED DEATH 1 RECEPTOR; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIGEMINUS GANGLION; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; RECEPTORS, VIRUS; TRIGEMINAL GANGLION; VIRUS LATENCY;

ANIMALIA; HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 79955444899     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02290-10     Document Type: Article

References (83)

1. Agata, Y., et al. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8:765-772.
2. Ahmed, M., and N. W. Fraser. 2001. Herpes simplex virus type 1 2-kilobase latency-associated transcript intron associates with ribosomal proteins and splicing factors. J. Virol. 75:12070-12080.
3. + T cells to immune senescence. J. Immunol. 183:4103-4108.
4. Allen, S. J., K. R. Mott, M. Zandian, and H. Ghiasi. 2010. Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in HSV-1 infected mice. J. Virol. 84:12315-12324.
5. Barber, D. L., et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687.
6. Barron, B. A., et al. 1994. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 101:1871-1882.
7. Branco, F. J., and N. W. Fraser. 2005. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis. J. Virol. 79:9019-9025.
8. Carpenter, D., et al. 2007. Stable cell lines expressing high levels of the herpes simplex virus type 1 LAT are refractory to caspase 3 activation and DNA laddering following cold shock induced apoptosis. Virology 369:12-18.
9. Chen, J., et al. 2011. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm. Res. 60:47-53.
10. Day, C. L., et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354.
11. Derfuss, T., V. Arbusow, M. Strupp, T. Brandt, and D. Theil. 2009. The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia. Ann. N. Y. Acad. Sci. 1164:300-304.
12. Dix, R. D. 2002. Pathogenesis of herpes simplex ocular disease, vol. 2. Lippincott, Williams and Wilkins, Philadelphia, PA.
13. Elsaesser, H., K. Sauer, and D. G. Brooks. 2009. IL-21 is required to control chronic viral infection. Science 324:1569-1572.
14. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U. S. A 88:790-794.
15. Feldman, L. T., et al. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U. S. A. 99:978-983.
16. + T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175: 8218-8225.
17. + T cell dysfunction in melanoma patients. J. Exp. Med. 207:2175-2186.
18. Fraser, N. W., et al. 1991. A review of the molecular mechanism of HSV-1 latency. Curr. Eye Res. 10:1-13.
19. Fraser, N. W., and T. Valyi-Nagy. 1993. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb. Pathog. 15:83-91.
20. Frohlich, A., et al. 2009. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324:1576-1580.
21. Goepfert, P. A., et al. 2000. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J. Virol. 74:10249-10255.
22. + T cells associated with reversible immune dysfunction. J. Virol. 81:9249-9258.
23. + T cells. J. Virol. 83:9122-9130.
24. Gordon, Y. J. 1990. Pathogenesis and latency of herpes simplex virus type 1 (HSV-1): an ophthalmologist's view of the eye as a model for the study of the virus-host relationship. Adv. Exp. Med. Biol. 278:205-209.
25. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
26. Hill, J. M., F. Sedarati, R. T. Javier, E. K. Wagner, and J. G. Stevens. 1990. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117-125.
27. + T cells. Blood 116:4501-4511.
28. Hufner, K., et al. 2009. Fewer latent herpes simplex virus type 1 and cytotoxic T cells occur in the ophthalmic division than in the maxillary and mandibular divisions of the human trigeminal ganglion and nerve. J. Virol. 83:3696-3703.
29. Inman, M., et al. 2001. Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. J. Virol. 75:3636-3646.
30. Jin, H. T., et al. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 107:14733-14738.
31. Jin, L., et al. 2003. Identification of herpes simplex virus type 1 latency-associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype. J. Virol. 77:6556-6561.
32. Jin, L., et al. 2007. Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript. J. Neurovirol. 13:78-84.
33. Jones, R. B., et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205:2763-2779.
34. Jurado, J. O., et al. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181:116-125.
35. + T cells and relieves the lupus-like nephritis of NZB/W F1 mice. J. Immunol. 184:2337-2347.
36. Kaufman, H. E., et al. 2005. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 46:241-247.
37. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704.
38. Keir, M. E., et al. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883-895.
39. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6:873-879.
40. Kramer, M. F., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1389-1399.
41. Latchman, Y. E., et al. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U. S. A. 101:10691-10696.
42. Margolis, T. P., et al. 2007. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81:11069-11074.
43. McGeoch, D. J., et al. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
44. Mossman, K. L., and J. R. Smiley. 2002. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:1995-1998.
45. + T cells in trigeminal ganglia of latently infected mice. J. Virol. 83:2246-2254.
46. + T cells. Mol. Vis. 13:1802-1812.
47. Mott, K. R., G. C. Perng, Y. Osorio, K. G. Kousoulas, and H. Ghiasi. 2007. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J. Virol. 81:12962-12972.
48. + dendritic cells are involved in enhancing HSV-1 latency. J. Virol. 82:9870-9879.
49. Mott, K. R., D. Underhill, S. L. Wechsler, T. Town, and H. Ghiasi. 2009. A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virol. J. 6:56.
50. Mueller, S. N., and R. Ahmed. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 106:8623-8628.
51. Mueller, S. N., et al. 2010. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J. Clin. Invest. 120:2508-2515.
52. Nicosia, M., J. M. Zabolotny, R. P. Lirette, and N. W. Fraser. 1994. The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comi-grating with ribosomal subunits during productive infection. Virology 204: 717-728.
53. Osorio, Y., and H. Ghiasi. 2003. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. J. Virol. 77:5774-5783.
54. Peng, W., et al. 2004. Mapping herpes simplex virus type 1 latency-associated transcript sequences that protect from apoptosis mediated by a plasmid expressing caspase-8. J. Neurovirol. 10:260-265.
55. Perng, G. C, et al. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055.
56. Perng, G. C, et al. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287:1500-1503.
57. Perng, G. C, et al. 2002. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J. Virol. 76:1224-1235.
58. Perng, G. C, et al. 2000. The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J. Virol. 74:1885-1891.
59. + T cell survival in HIV infection. J. Exp. Med. 203:2281-2292.
60. + T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110:928-936.
61. Remeijer, L., J. Maertzdorf, P. Doornenbal, G. M. Verjans, and A. D. Osterhaus. 2001. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 357:442.
62. Robert, P. Y., J. P. Adenis, F. Denis, S. Alain, and S. Ranger-Rogez. 2003. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J. Med. Virol. 71:69-74.
63. Rock, D. L., et al. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826.
64. Rodriguez-Manzanet, R., R. DeKruyff, V. K. Kuchroo, and D. T. Umetsu. 2009. The costimulatory role of TIM molecules. Immunol. Rev. 229:259-270.
65. Sabatos, C. A., et al. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4:1102-1110.
66. Sachdeva, M., M. A. Fischl, R. Pahwa, N. Sachdeva, and S. Pahwa. 2010. Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 54:447-454.
67. Sakuishi, K., et al. 2010. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207:2187- 2194.
68. Sawtell, N. M. 1997. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71:5423-5431.
69. Sawtell, N. M., D. K. Poon, C. S. Tansky, and R. L. Thompson. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72:5343- 5350.
70. Steiner, I. 1996. Human herpes viruses latent infection in the nervous system. Immunol. Rev. 152:157-173.
71. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
72. + T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202.
73. Urbani, S., et al. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403.
74. Vali, B., et al. 2010. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur. J. Immunol. 40:2493-2505.
75. Wagner, E. K., et al. 1988. The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J. Virol. 62:4577-4585.
76. Wechsler, S. L., A. B. Nesburn, R. Watson, S. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:3101-3106.
77. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058.
78. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927.
79. Wherry, E. J., et al. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670-684.
80. Wilhelmus, K. R., et al. 1996. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br. J. Ophthalmol. 80:969-972.
81. Willey, D. E., M. D. Trousdale, and A. B. Nesburn. 1984. Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest. Ophthalmol. Vis. Sci. 25:945-950.
82. Yi, J. S., M. Du, and A. J. Zajac. 2009. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324:1572-1576.
83. Zajac, A. J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.